EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update

Conclusions
These updated EULAR recommendations provide consensus on RA management including safety, effectiveness and cost.

Source: Annals of the Rheumatic Diseases - January 3, 2023 Category: Rheumatology Authors: Smolen, J. S., Landewe, R. B. M., Bergstra, S. A., Kerschbaumer, A., Sepriano, A., Aletaha, D., Caporali, R., Edwards, C. J., Hyrich, K. L., Pope, J. E., de Souza, S., Stamm, T. A., Takeuchi, T., Verschueren, P., Winthrop, K. L., Balsa, A., Bathon, J. M., Tags: ARD, EULAR papers Recommendation Source Type: research